Skip to main content
. 2019 Aug 6;23(3):317–329. doi: 10.1007/s00737-019-00994-0

Table 2.

OT administration trials in postpartum women

Year Author RCT Sample Dose (IU) Min. to task Stimuli/task Neuroanatomic, psychophysiological and neuroendocrine response to OT (vs PL) Psychological responses to OT (vs PL)
2015 Gregory et al. DBPLBS 29 breastfeeding mothers and 30 NP controls 24 30 IAPS images (sexual, neutral, or infant)

PP and NP:

↑ VTA (to infant and sexual images);

↔ NAc (to any image)

----
2013 Rupp et al. IAPS images (sexual, neutral, crying infant, smiling infant)

PP (vs NP) under PL:

↓ right AMY activation to all images;

PP (vs NP) under OT:

↔ right AMY to all images

PP (vs NP) under PL and OT:

↓ sexual arousal scores.

↓ arousal to infant images

NP (vs PP) under OT:

↔ arousal to infant stimuli.

2014 Rupp et al. IAPS images (neutral and negative)

PP and NP:

↔ cortisol

PP (vs NP) under PL:

↓ rAMY to negative images

NP (vs PP) under OT

↓ rAMY to negative images

PP (vs NP) under PL:

↓ arousal to negative images;

PP (vs NP) under OT:

↔ arousal to negative images

2013 Mah et al. DBPLWS 25 mothers with PPD (infants 3–12 months) 24 45 Infant interaction session ----

↓ mood

↑ ratings of their child as ‘difficult’

↑quality of the mother-child relationship

2015 24 55 Enthusiastic stranger paradigm ----

↑ maternal protectiveness of their child

↓gaze duration

2017 24 30–55 Crying paradigm ----

↑ perceiving infant cry as urgent

↑ harsh caregiving strategy upon infant cry

↔ maternal sensitivity

2015 Clarici et al. DBPLBS 5 mothers with PPD - OT and 11 with PPD – PL

16

daily

---- 12 weekly psychodynamic therapy sessions ----

↔ depressive symptoms

↔ basic emotional traits (including attachment)

↓ self-centered in depressive presentation (therapist ratings)

↑, increased; ↓, decreased; ↔, no effect/similar; ----, not applicable/unknown; CO, cross over; BS, between subjects; WS, within subjects; DB, double-blind; PP, postpartum; PPD, postpartum depression; NP, nulliparous; HC, healthy controls; PL, placebo; OT, oxytocin; VTA, ventral tegmental area; NAc, nucleus accumbens; AMY, amygdala